Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

Highlights from last week’s European Association for the Study of Diabetes’ (EASD) virtual 2020 conference included announcements on the Guardian Sensor 4 Continuous Glucose Monitoring (CGM) and the Omnipod 5 Automated Insulin Delivery (AID) system, new data on the importance of time in range, and updated recommendations on SGLT-2s, GLP-1s, and combination therapies Continue Reading »

Experts discussed the greatest challenges in diabetes in 2020, including the COVID-19 pandemic, and the most critical changes we need to make to address them during diaTribe’s Solvable Problems event Continue Reading »

Latest results presented at the European Society of Cardiology conference show that SGLT-2 inhibitor therapies Jardiance and Farxiga clearly lead to heart and kidney health Continue Reading »

In exciting news for digital diabetes prevention programs, a new study showed that highly engaged participants – those who more frequently engaged in food logging, lessons, and physical activity – were more likely to lose weight Continue Reading »

A summary of the landmark trials that show that careful blood glucose management can lower the risk of long-term health complications in people with type 1 or type 2 diabetes  Continue Reading »

The microbiome is an exciting area of research for diabetes management. What do we know and what questions do we still have about the microbiome? Continue Reading »

What is the link between vision loss and mental health outcomes, and how can eye exams tell us what is going on in the brain and the body? Continue Reading »

dQ&A surveyed 2,540 CGM users with type 1 or type 2 diabetes to find out how aware they are of their own time in range: 87% of respondents knew how much time they spend in range daily Continue Reading »

Pages